A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)

This study has been completed.
Information provided by:
Alcon Research
ClinicalTrials.gov Identifier:
First received: January 3, 2003
Last updated: August 4, 2008
Last verified: August 2008
To compare the safety and IOP-lowering efficacy of TRAVATAN and XALCOM in subjects with open-angle glaucoma or ocular hypertension.

Condition Intervention Phase
Glaucoma, Open-Angle
Ocular Hypertension
Drug: Travoprost (0.004%)
Drug: Latanoprost (0.005%)/Timolol (0.5%)
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: A 6-Week Safety and Efficacy Study of TRAVATAN Compared to XALCOM in Subjects With Open-Angle Glaucoma or Ocular Hypertension.

Resource links provided by NLM:

Further study details as provided by Alcon Research:

Study Start Date: January 2001
Study Completion Date: July 2004
Primary Completion Date: July 2004 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Patients of any race and either sex with open-angle glaucoma (with or without pigment dispersion or pseudoexfoliation component) or ocular hypertension.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00051155

United States, Texas
Fort Worth, Texas, United States
Sponsors and Collaborators
Alcon Research
Principal Investigator: Alcon Investigators Alcon Research
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00051155     History of Changes
Other Study ID Numbers: C-01-74
Study First Received: January 3, 2003
Last Updated: August 4, 2008
Health Authority: United States: Food and Drug Administration

Keywords provided by Alcon Research:

Additional relevant MeSH terms:
Glaucoma, Open-Angle
Ocular Hypertension
Cardiovascular Diseases
Eye Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on November 24, 2015